Inventor · disambiguated record
David Azria
Also filed as: AZRIA DAVID
2 granted patents·5 pending applications·0 citations·filing 2006–2020
26Inventor score
Files withINST REGIONAL CANCER MONTPELLIER2COMMISSARIAT ENERGIE ATOMIQUE1CT HOSPITALIER UNIVERSITAIRE MONTPELLIER1INSTUT NAT DE LA SANTE ET DE L1L'INSTITUT NAT DE LA SANTE ET DE LA RECH MEDICALE1
Top patents by PatentIndex Score
7 records- 0148US9522956B2Combination therapy using anti-EGFR and anti-HER2 antibodiesL'INSTITUT NAT DE LA SANTE ET DE LA RECH MEDICALE·Filed 2014·Granted Dec 20, 2016·0 cites·15 claims
- 0246US2009214541A1Combination Therapy Using Anti-EGFR and Anti-HER2 AntibodiesINSTUT NAT DE LA SANTE ET DE L·Filed 2006·Application pending·0 cites
- 0334US2022137030A1In vitro method for assessing the risk of prostate side effect after treatment by ionizing radiationINST REGIONAL CANCER MONTPELLIER·Filed 2020·Application pending·0 cites
- 0433US2022157462A1In vitro method for assessing the risk of prostate side effect after treatment by ionizing radiationNOVAGRAY·Filed 2020·Application pending·0 cites
- 0532US10001491B2Method for determining radiosensitivityCT HOSPITALIER UNIVERSITAIRE MONTPELLIER·Filed 2014·Granted Jun 19, 2018·0 cites·10 claims
- 0628US2018363057A1Method for evaluating individual radiosensitivity and the risk of adverse effectsCOMMISSARIAT ENERGIE ATOMIQUE·Filed 2016·Application pending·0 cites
- 0723US2024021315A1In vitro method for predicting the risk of developing a breast late effect after radiotherapyINST REGIONAL CANCER MONTPELLIER·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when David Azria files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →